| Dr Miles Wayne Howard, MD | |
|
10815 W Mcdowell Rd Ste 301, Avondale, AZ 85392-5016 | |
| (623) 535-0740 | |
| (623) 535-0741 |
| Full Name | Dr Miles Wayne Howard |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 10815 W Mcdowell Rd Ste 301, Avondale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548215783 | NPI | - | NPPES |
| 179665 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 21113 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alium Health, Llc | 8123375789 | 7 |
News Archive
Whether you like your coffee black, decaf, half-caff or even instant, feel free to drink up. Researchers at the University of Southern California (USC) Norris Comprehensive Cancer Center of Keck Medicine of USC have found that coffee consumption decreases the risk of colorectal cancer.
Bond Laboratories, Inc., a leading manufacturer and marketer of proprietary beverage products and health supplements, today announced revenue of over $2.2 million for the third quarter ended September 30, 2009, a 340% increase over revenue of approximately $500,000 for the comparable quarter in 2008.
In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease.
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
› Verified 8 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
Whether you like your coffee black, decaf, half-caff or even instant, feel free to drink up. Researchers at the University of Southern California (USC) Norris Comprehensive Cancer Center of Keck Medicine of USC have found that coffee consumption decreases the risk of colorectal cancer.
Bond Laboratories, Inc., a leading manufacturer and marketer of proprietary beverage products and health supplements, today announced revenue of over $2.2 million for the third quarter ended September 30, 2009, a 340% increase over revenue of approximately $500,000 for the comparable quarter in 2008.
In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease.
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
› Verified 8 days ago
| Entity Name | Nicholas Bujak Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821484171 PECOS PAC ID: 5294033114 Enrollment ID: O20160411000026 |
News Archive
Whether you like your coffee black, decaf, half-caff or even instant, feel free to drink up. Researchers at the University of Southern California (USC) Norris Comprehensive Cancer Center of Keck Medicine of USC have found that coffee consumption decreases the risk of colorectal cancer.
Bond Laboratories, Inc., a leading manufacturer and marketer of proprietary beverage products and health supplements, today announced revenue of over $2.2 million for the third quarter ended September 30, 2009, a 340% increase over revenue of approximately $500,000 for the comparable quarter in 2008.
In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease.
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
› Verified 8 days ago
| Entity Name | Alium Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619484037 PECOS PAC ID: 8123375789 Enrollment ID: O20180727001702 |
News Archive
Whether you like your coffee black, decaf, half-caff or even instant, feel free to drink up. Researchers at the University of Southern California (USC) Norris Comprehensive Cancer Center of Keck Medicine of USC have found that coffee consumption decreases the risk of colorectal cancer.
Bond Laboratories, Inc., a leading manufacturer and marketer of proprietary beverage products and health supplements, today announced revenue of over $2.2 million for the third quarter ended September 30, 2009, a 340% increase over revenue of approximately $500,000 for the comparable quarter in 2008.
In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease.
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Miles Wayne Howard, MD Po Box 25317, Tampa, FL 33622-5317 Ph: (813) 286-0033 | Dr Miles Wayne Howard, MD 10815 W Mcdowell Rd Ste 301, Avondale, AZ 85392-5016 Ph: (623) 535-0740 |
News Archive
Whether you like your coffee black, decaf, half-caff or even instant, feel free to drink up. Researchers at the University of Southern California (USC) Norris Comprehensive Cancer Center of Keck Medicine of USC have found that coffee consumption decreases the risk of colorectal cancer.
Bond Laboratories, Inc., a leading manufacturer and marketer of proprietary beverage products and health supplements, today announced revenue of over $2.2 million for the third quarter ended September 30, 2009, a 340% increase over revenue of approximately $500,000 for the comparable quarter in 2008.
In an announcement today, Mount Sinai School of Medicine and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease.
An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).
› Verified 8 days ago
Justice Huy Duc Tran, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3400 N Dysart Rd, Building F, Ste 121 & 123, Avondale, AZ 85392 Phone: 623-792-8397 Fax: 623-544-5187 | |
Shashank Shekhar Srivastava, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 301, Avondale, AZ 85392 Phone: 623-512-4466 Fax: 623-512-4460 | |
Mr. Randall James Reid, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10815 W. Mcdowell Rd, Ste 301, Avondale, AZ 85392 Phone: 623-433-0106 Fax: 623-433-0108 | |
Liani Kelly Mccline, PA-C Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 301, Avondale, AZ 85392 Phone: 623-535-0740 Fax: 623-512-4460 | |
George Davidson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 301, Avondale, AZ 85392 Phone: 623-535-0740 Fax: 623-535-0741 | |
Shahrzad Borhan-manesh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3400 N Dysart Rd, Ste 121, Avondale, AZ 85392 Phone: 623-583-3001 Fax: 623-583-3007 |